CB
Insider
Christopher S. Boerner
Chief Executive OfficerChristopher S. Boerner (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Bristol-Myers Squibb Company (BMY). Across 1 priced purchase filing, the average 21-session return was +9.8% from execution and +10.2% from disclosure (delay-adjusted; derived). The largest single filing was $110K of BMY (2,000 sh × $55.05, as filed), executed Feb 20 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+9.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+10.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$110K
shares × price, as filed
Last traded
Feb 20 2025
Filed Feb 21 2025
Median ADV $761.0M across their filed names
Open performance→Volume by month
Buys $110K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
BMYRecent filings
BMYPURCHASE
Bristol-Myers Squibb Company
View filing →
$110K2,000 sh × $55.05
Exec Feb 20 2025
Filed Feb 21 2025 · 5:30 PM ET